Application of immunotherapy in esophageal squamous cell carcinoma
10.3760/cma.j.cn112434-20210818-00276
- VernacularTitle:免疫治疗在食管鳞状细胞癌中的应用
- Author:
Jianwei ZHU
1
;
Qiang WU
;
Yi LU
;
Cong WU
;
Fei SUN
;
Boyou ZHANG
;
Hongcan SHI
Author Information
1. 扬州大学医学院（转化医学研究院） 扬州大学临床医学院 江苏省中西医结合老年病防治重点实验室，扬州 225009
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2022;38(11):681-687
- CountryChina
- Language:Chinese
-
Abstract:
Esophageal cancer is one of the top ten of the world's most common cancer. Although the incidence of esophageal squamous cell carcinoma (ESCC) in some high-risk areas in East Asia has being decreasing, it is still the most common histologic subtypes. A great many of patients with ESCC not only are diagnosed in an advanced stage but also have a high mortality rate. With the application of tumor immunotherapy in ESCC treatment in recent years, the prognosis of ESCC patients has been improved to a certain extent. This article intends to review the research progress of immunotherapy in esophageal squamous cell carcinoma.
